Regeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
Regeneron is recalling 21,353 vials of Libtayo (cemiplimab-rwlc) injection nationwide due to a lack of assurance of sterility.
- Product
- LIBTAYO — LIBTAYO (CEMIPLIMAB-RWLC)
- Category
- Drug
- Distribution
- Distributed nationwide